Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Max Application is an Italian software company that develops Oracle-based enterprise applications, with a notable focus on pharmacovigilance and drug safety software for pharmaceutical companies. Its flagship healthcare product, SafetyDrugs, is a commercial pharmacovigilance database used for adverse event case management and regulatory compliance from clinical trials through post-marketing surveillance. The company also offers ERP and business intelligence solutions for industrial and commercial customers, along with SaaS deployment on Oracle Cloud, validation support, and related IT services. Max Application is not a drug developer, biotech, or pharmaceutical manufacturer; it is best characterized as a healthcare IT and vertical enterprise software company serving the pharma industry. In 2024, the company joined Abacus Group while continuing to operate under the Max Application brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Max Application.